Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia

Overview of attention for article published in OncoTargets and therapy, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page

Readers on

mendeley: 6 Mendeley

Summary News X Facebook

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,680 followers.

RT @richeslab: Just out - our review of the latest developments in #CLL therapeutics: https://t.co/UvBJ6NErWb A massive thanks to Manabu Ha…

03 Apr 2024

Reply Repost Favourite

Just out - our review of the latest developments in #CLL therapeutics: https://t.co/UvBJ6NErWb A massive thanks to Manabu Hayama who did a great job with this!

08 Mar 2024

Reply Repost Favourite

Dove Medical Press

Article Metrics

Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia

About this Attention Score

Mentioned by

Readers on